Last price paid | 0.32 | |
Change | +6.67% [ +0.02 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 14.05.2024 17:20 |
Fixing | n.a. |
Settlement date | 10.11.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +116.67% |
Year to date (YTD) | +88.24% |
1 month | +23.08% |
3 months | +68.42% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.15 |
Underlying price on issue | 35.80 |
Premium | 0.03% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281039391 |
Symbol | IBSA4Z |
Security | 128103939 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Basilea Pharmaceu N, CH0011432447 |
Underlying ISIN | CH0011432447 |
Funding level | 29.530300 |
Stop-loss level | 30.345500 |
Distance to stop-loss level | 31.50% |
Long/Short type | Long |
Subscription ratio | 50.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 08.11.2023 |
Premium | 3.32% |
Premium p.a. | n.a. |
Leverage | 2.73 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 14.774300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Swiss Re | 107.65 |
ZURICH INSURANCE | 469.10 |
ROCHE GS | 234.80 |
LOGITECH INT. | 81.60 |
Swiss Life Hldg | 662.60 |
Name | Price |
---|---|
Holcim | 78.44 |
ABB Ltd | 47.65 |
UBS | 27.42 |
Lonza Group | 527.40 |
NOVARTIS N | 92.62 |